BOCA RATON, Fla., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq:SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), today announced that Joe Sardano, President and Chief Executive Officer, will present at the following upcoming investor conferences in September:
| 19th Annual Rodman & Renshaw Global Investment Conference | ||
| Date and Time: | Monday, September 11, 2017 at 4:15 p.m. Eastern time | |
| Venue: | Lotte New York Palace Hotel in New York City | |
| Sidoti & Company Fall 2017 Conference | ||
| Date and Time: | Thursday, September 28, 2017 at 11:25 a.m. Eastern time | |
| Venue: | New York Marriott Marquis at Times Square | |
Due to Hurricane Irma's South Florida expected path, management is cancelling its presentation at the 6th Annual Liolios Gateway Conference on September 6, 2017.
Mr. Sardano’s presentation at the Rodman & Renshaw Global Investment Conference will be webcast live and available for replay in the Investor Relations section of the Company’s website at sensushealthcare.com.
About Sensus Healthcare
Sensus Healthcare, Inc. is a medical device company that is committed to providing non-invasive and cost-effective treatment for non-melanoma skin cancers and keloids. Sensus uses a proprietary low energy X-ray technology known as superficial radiation therapy (SRT), which is a result of over a decade of dedicated research and development. Sensus has successfully incorporated SRT therapy into its portfolio of treatment devices, the SRT-100™ and SRT-100 Vision™. To date, SRT technology has been used to effectively and safely treat oncological and non-oncological skin conditions in thousands of patients. For more information, visit http://www.sensushealthcare.com.
Contact:
LHA Investor Relations
Kim Sutton Golodetz
(212) 838-3777
kgolodetz@lhai.com